Matinas BioPharma Provides Business Update and 2023 Strategic Outlook
January 30, 2023 16:01 ET
|
Matinas BioPharma Holdings, Inc.
2022 Success Has Increased Confidence to Focus LNC Delivery Platform on the Future of Medicine - Delivering Genes Prioritization on Building External Partnerships and an Internal Pipeline Centered...
Cytokinetics Announces Recipients of Its Fifth Annual Communications Grant Program
January 30, 2023 07:30 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the recipients of its fifth annual Communications Grant Program, intended to...
Evoke Announces Teva Ends Pursuit of Paragraph IV ANDA Against Gimoti
January 30, 2023 07:00 ET
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved By Medsafe In New Zealand
January 27, 2023 08:45 ET
|
Amarin Corporation plc
DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Medsafe in New Zealand has granted approval to VAZKEPA (icosapent...
Psycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSD
January 26, 2023 12:15 ET
|
Psycheceutical Bioscience, Inc.
MIAMI, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge treatments for...
INmune Bio, Inc. Announces Pre-Clinical Data That Support a Pioneering Approach to Treating Duchenne Muscular Dystrophy
January 25, 2023 07:45 ET
|
INmune Bio, Inc.
Boca Raton, Florida, Jan. 25, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the...
Enormous Investments in Biotechnology to Propel the Gene Synthesis Market Grow at 19.2% from 2023 to 2033: Future Market Insights, Inc.
January 23, 2023 08:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Jan. 23, 2023 (GLOBE NEWSWIRE) -- As per FMI, the gene synthesis market is expected to reach US$ 779.4 million in 2023. Furthermore, the market is projected to record a CAGR of 19.2%...
Dr. Matt Cahill Appointed Chief Operating Officer of Qu Biologics
January 23, 2023 08:00 ET
|
Qu Biologics, Inc.
BURNABY, British Columbia, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of...
BiondVax’s Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo Study
January 23, 2023 06:25 ET
|
BiondVax Pharmaceuticals Ltd.
COVID-19 illness was virtually prevented in hamsters administered BiondVax’s inhaled NanoAb and infected three hours later with SARS-CoV-2 Data further strengthens value proposition of BiondVax’s...
Ryan Davies Conducts CEO Chat with Leading Biotech IP Expert
January 20, 2023 03:01 ET
|
CancerVAX, Inc
LEHI, Utah, Jan. 20, 2023 (GLOBE NEWSWIRE) -- CancerVAX, Inc., a pre-clinical biotechnology company developing immunotherapy cancer treatments that use the body’s immune system to fight cancer,...